BE847095A - Comprime pour la liberation controlee d'un medicament et sa preparation, - Google Patents

Comprime pour la liberation controlee d'un medicament et sa preparation,

Info

Publication number
BE847095A
BE847095A BE171358A BE171358A BE847095A BE 847095 A BE847095 A BE 847095A BE 171358 A BE171358 A BE 171358A BE 171358 A BE171358 A BE 171358A BE 847095 A BE847095 A BE 847095A
Authority
BE
Belgium
Prior art keywords
tablet
preparation
controlled release
medicinal product
medicinal
Prior art date
Application number
BE171358A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE847095A publication Critical patent/BE847095A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
BE171358A 1975-10-10 1976-10-08 Comprime pour la liberation controlee d'un medicament et sa preparation, BE847095A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62131675A 1975-10-10 1975-10-10

Publications (1)

Publication Number Publication Date
BE847095A true BE847095A (fr) 1977-01-31

Family

ID=24489671

Family Applications (1)

Application Number Title Priority Date Filing Date
BE171358A BE847095A (fr) 1975-10-10 1976-10-08 Comprime pour la liberation controlee d'un medicament et sa preparation,

Country Status (16)

Country Link
JP (1) JPS5264420A (nl)
AU (1) AU516051B2 (nl)
BE (1) BE847095A (nl)
CA (1) CA1097220A (nl)
CH (1) CH616843A5 (nl)
DE (1) DE2645547A1 (nl)
DK (1) DK454876A (nl)
FR (1) FR2326933A1 (nl)
GB (1) GB1568837A (nl)
HU (1) HU175540B (nl)
IE (1) IE44540B1 (nl)
NL (1) NL7611148A (nl)
NO (1) NO763450L (nl)
PH (1) PH14564A (nl)
SE (1) SE435569B (nl)
ZA (1) ZA765931B (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU806037A1 (ru) * 1978-04-06 1981-02-23 Всесоюзный Кардиологический Научныйцентр Amh Cccp Антиангинальное средство
JPS5626810A (en) * 1979-08-06 1981-03-16 Kurishiyuna Mitora Arun Antiacid delivering form controlled and treating method using said form
FR2494112B1 (nl) * 1980-11-19 1986-01-10 Laruelle Claude
EP0094117A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
AU1873783A (en) * 1982-10-08 1984-04-12 Verex Laboratories Inc. Constant release formulation
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
HU190619B (en) 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
DE3448522C2 (de) * 1983-11-11 1995-08-24 Egyt Gyogyszervegyeszeti Gyar Pharmazeutische Präparate, insbesondere Tabletten, mit geregelter beziehungsweise verzögerter Wirkstoffabgabe, sowie Verfahren zur Herstellung derselben
FR2556965B1 (fr) * 1983-12-21 1986-08-22 Rhone Poulenc Sante Nouvelle forme galenique du ketoprofene a liberation controlee
DE3420666A1 (de) 1984-06-02 1985-12-05 Mannesmann Rexroth GmbH, 8770 Lohr Niveauregeleinrichtung fuer fahrzeuge mit mindestens einem hydraulischen schwingungsdaempfer
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
JPH0667828B2 (ja) * 1985-10-09 1994-08-31 日研化学株式会社 バルプロ酸ナトリウムの持続性顆粒製剤
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
US5277916A (en) * 1988-02-01 1994-01-11 F. H. Faulding & Co., Ltd. Tetracycline dosage form
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
GB8913889D0 (en) * 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
IL119627A (en) 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet

Also Published As

Publication number Publication date
IE44540B1 (en) 1981-12-30
DE2645547A1 (de) 1977-04-14
NO763450L (nl) 1977-04-13
DK454876A (da) 1977-04-11
CH616843A5 (en) 1980-04-30
GB1568837A (en) 1980-06-04
FR2326933B1 (nl) 1979-03-02
PH14564A (en) 1981-09-24
ZA765931B (en) 1977-09-28
AU516051B2 (en) 1981-05-14
CA1097220A (en) 1981-03-10
AU1844676A (en) 1978-04-13
SE7611241L (sv) 1977-04-11
IE44540L (en) 1977-04-10
JPS5264420A (en) 1977-05-27
SE435569B (sv) 1984-10-08
FR2326933A1 (fr) 1977-05-06
HU175540B (hu) 1980-08-28
NL7611148A (nl) 1977-04-13

Similar Documents

Publication Publication Date Title
BE847095A (fr) Comprime pour la liberation controlee d'un medicament et sa preparation,
IT8023228A0 (it) Composizione farmaceutica a cessione prolungata contenente un medicamento solido e procedimento per la sua preparazione.
ZA795530B (en) Pharmaceutical tablet for oral administration and process for its manufacture
BE867692A (fr) Dispositif fournissant une liberation entretenue d'un medicament.
LU78845A1 (fr) Moyen pour l'administration de medicaments a travers la peau
BE762948A (fr) Appareil distributeur de dose d'un medicament sous la forme d'aerosol
GR58257B (en) Novel pharmaceutical preparation adapted for oral administration
NO146456C (no) Fremgangsmaate for fremstilling av kapsellegeme, saerlig for medisindoseringskapsel
JPS54135219A (en) Orally dosing solid pharmaceutical preparation and production
FI792863A (fi) Foerfarande foer igaongsaettning av aongpanna med tvaongscirkulation
GR60341B (en) A substained release pharmaceutical tablet
BE845613A (fr) Preparations pharmaceutiques pour l'administration orale renfermant un ester-17beta de nandrolone et nouveaux esters- 17beta de nandrolone
JPS55147223A (en) Pharmaceutical medicine
BE841003A (fr) Procede de preparation de doses pharmaceutiques solides a liberation etalee
FR2344291A1 (fr) Composition pour l'application topique d'un medicament
FR2324608A1 (fr) Derives de l'hydroxy-4 cyclopentene-2-one-1 utilisables pour la fabrication de medicaments, et preparation de ces substances
BE844532A (fr) Medicament a base d'un derive du benzothiadiazole
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
BE858507A (fr) Medicament antagoniste de l'action de la gastrine et des polypeptides apparentes
FR2351994A1 (fr) Composes 9-(5-o-acyl-b-d-arabinofuranosyl)-adeniniques, procede pour leur preparation et application en tant que medicaments
JPS5377073A (en) Piperadine derivative compound and its production and medical drugs containing said compound
BE843255A (fr) Nouvelles amidines terpenoaromatiques utilisables comme medicament
JPS5259167A (en) 1*44benzodioxane and medicines for circulatory disease and asthma
FR2303555A1 (fr) Nouvel antibiotique, sa preparation et medicament le contenant
ZA707072B (en) Process for the manufacture of a drug dosage form permitting controlled release of active ingredient

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: E.R. SQUIBB & SONS INC.

Effective date: 19851031